all report title image

GLOBAL NON OPIOID PAIN TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Non Opioid Pain Treatment Market, By Drug Type (Non-Steroidal Anti-Inflammatory Drugs, Steriods, Analgesics, Corticosteroids, Others), By Indication (Musco Skeletal Disorders, Central Nervous System Disorders, Traumatic Pain, Chronic Pain, Others), By Route of Administration (Topical, Intravenous, Oral), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Mar 2024
  • Code : CMI6741
  • Pages :164
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Global Non Opioid Pain Treatment Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increased Awareness about Opioid Epidemic

The ongoing public health crisis arising from misuse and overprescription of opioid medicines in countries like U.S. has brought the drawbacks of opioids under intense global scrutiny. Various entities ranging from public health organizations to governments are engaged in initiatives aimed at curbing inappropriate usage of these highly addictive drugs. At the same time, educational programs are being conducted to spread awareness among patients and medical practitioners about risks of long term use of opioids, alternative treatment options and importance of achieving an optimal pain treatment regimen. For instance, in August 2023, On International Overdose Awareness Day, the Biden-Harris administration announced August 27–September 2 as Overdose Awareness Week to draw attention to the damage caused by illicit fentanyl and other drugs. The White House Office of National Drug Control Policy will invest an additional US$ 1 Mn in its Real Deal on Fentanyl campaign with the Ad Council. The initiative tries to reach out to young people, who are the fastest-growing age group in the U.S. for opioid overdoses.

Key Players Insights
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd. 
  • Sun Pharmaceutical Industries Ltd.  
  • Cipla Inc. 
  • Fresenius Kabi AG 
  • GSK
  • Vertex Pharmaceuticals Incorporated
  • Pacira BioSciences
  • Collegium Pharmaceuticals
  • Cara Therapeutics
  • Akelos
  • Fidia Farmaceutici S.p.A. 
  • Sanofi 
  • Eli Lilly and Company
  • Merck & Co
  • Acorda Therapeutics
  • Hyloris Pharmaceuticals
  • Hikma Pharmaceuticals PLC

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.